Murielle M. Ellison;Kenneth W. Walker;Edward J. Belouski;Randy I. Hecht;Yue-Sheng Li;Colin V. Gegg, Jr.;Mark L. Michaels;Jing Xu
发明人:
Kenneth W. Walker,Colin V. Gegg, Jr.,Randy I. Hecht,Edward J. Belouski,Yue-Sheng Li,Mark L. Michaels,Jing Xu,Murielle M. Ellison
申请号：
US13123205
公开号：
US09279013B2
申请日:
2009.10.08
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides, FGF21 mutant polypeptides comprising extended in vivos half-lives, pharmaceutical compositions comprising FGF21 mutant polypeptides having extended in vivos half lives, and methods for treating metabolic disorders using such nucleic acids, polypeptides, or pharmaceutical compositions.
